Science Explorer Interactive view Map
Company · San Francisco · United States

Rigel (United States)

rigel.comROR OpenAlex
World rank, all time
#22,268
of 42,892
Rank in United States
#4,810
of 8,685
Research works
129
◆ 1% vs 2013–17
Citations
4.2k
32.9 per fractional work
Top-10% rate
10.0%
record average 16.5%
Open access
37%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.45× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.12× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 14.49× its world share, 2 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 18.20× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.70× its world share, 0 worksChemistryComputer Science: 0.33× its world share, 0 worksComputer ScienceEnvironmental Science: 0.22× its world share, 0 worksEnvironmental ScienceMedicine: 2.69× its world share, 8 worksMedicineDecision Sciences: 1.11× its world share, 0 worksDecision SciencesSocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 18.2×. Every wedge is a field page.

Who are the top researchers at Rigel (United States)?

Ranked on the composite score, Esteban S. Masuda and Vanessa Taylor lead among researchers whose main affiliation is Rigel (United States).

  1. 1 Esteban S. Masuda United States · #332,134 worldwide 90 citations · 18 works
  2. 2 Vanessa Taylor United States · #812,704 worldwide 22 citations · 16 works
All ranked researchers at Rigel (United States)

Which keywords describe research at Rigel (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Cancer Therapy, Rituximab, Immune Response, Mutation, Cytokines and Immune Responses.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation25▲ 8.2×28 topics
  2. Cancer12▲ 6.5×21 topics
  3. Epidemiology8▲ 1.61×18 topics
  4. Cancer Therapy8▲ 9.9×9 topics
  5. Rituximab6▲ 30×4 topics
  6. Immune Response6▲ 7.6×8 topics
  7. Mutation6▲ 30×3 topics
  8. Cytokines6▲ 17×3 topics
  9. Immune Responses6▲ 46×3 topics
  10. Allergic Disease5▲ 178×1 topic
  11. Mast Cells5▲ 178×1 topic
  12. Prognostic Factors5▲ 9.3×8 topics
  13. Thrombosis5▲ 18×5 topics
  14. Glycosylation5▲ 17×3 topics
  15. Tumor Microenvironment5▲ 11×5 topics
  16. Management5▲ 4.7×9 topics
  17. Tumor Suppression4▲ 29×3 topics
  18. Pattern Recognition Receptors4▲ 22×2 topics
  19. Fc Receptors4▲ 31×1 topic
  20. Therapeutic Antibodies4▲ 24×1 topic
  21. Therapeutic Targets4▲ 13×3 topics
  22. Cancer Immunotherapy4▲ 21×3 topics
  23. Chronic Lymphocytic Leukemia4▲ 59×1 topic
  24. Genomic Aberrations4▲ 59×1 topic
  25. Medicinal Chemistry4▲ 7.7×7 topics
  26. Toll-like Receptors4▲ 17×2 topics
  27. BCR-ABL4▲ 100×1 topic
  28. Imatinib4▲ 100×1 topic
  29. Cytokine-Mediated Link4▲ 39×1 topic
  30. Drug Discovery4▲ 6.8×7 topics
  31. Innate Antiviral Responses4▲ 39×1 topic
  32. IL-63▲ 80×1 topic
  33. STAT33▲ 80×1 topic
  34. Apoptosis3▲ 6.5×6 topics
  35. Hemostasis3▲ 16×2 topics
  36. Immune Thrombocytopenic Purpura3▲ 60×1 topic
  37. Platelets3▲ 37×1 topic
  38. Proteasome Inhibitors3▲ 34×2 topics
  39. Immune Regulation3▲ 17×3 topics
  40. Immunosuppressive Therapy3▲ 12×4 topics

Which research topics does Rigel (United States) publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Pharmacological Effects of Natural Compounds, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.

Acute Myeloid Leukemia R…1Acute Myeloid Leukemia Research: 1 fractional worksPharmacological Effects …1Pharmacological Effects of Natural Compounds: 1 fractional worksMyeloproliferative Neopl…1Myeloproliferative Neoplasms: Diagnosis and Treatment: 1 fractional worksChronic Myeloid Leukemia…1Chronic Myeloid Leukemia Treatments: 1 fractional worksPlatelet Disorders and Treatments: 1 fractional worksPancreatic function and diabetes: 1 fractional worksMetabolism, Diabetes, an…1Metabolism, Diabetes, and Cancer: 1 fractional worksChronic Lymphocytic Leuk…1Chronic Lymphocytic Leukemia Research: 1 fractional worksCytokine Signaling Pathw…0Cytokine Signaling Pathways and Interactions: 0 fractional worksImmune Response and Infl…0Immune Response and Inflammation: 0 fractional works
HematologyPharmacologyGeneticsSurgery3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acute Myeloid Leukemia Research Hematology 1 works
  2. 2 Pharmacological Effects of Natural Compounds Pharmacology 1 works
  3. 3 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 1 works
  5. 5 Platelet Disorders and Treatments Hematology 1 works
  6. 6 Pancreatic function and diabetes Surgery 1 works
  7. 7 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
  8. 8 Chronic Lymphocytic Leukemia Research Genetics 1 works
  9. 9 Cytokine Signaling Pathways and Interactions Oncology 0 works
  10. 10 Immune Response and Inflammation Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.9%not open63.1%

World: 28% of research is openly available.

with international co-authors21.3%domestic only78.7%

World: 19% is written across borders.

How has Rigel (United States)'s research output changed?

Output in 2018–2022 was 1% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.